Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.31 |
| ▸ | PPARG | P37231 | 2/20 | 0.30 |
| ▸ | PPARA | Q07869 | 2/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19690451 | 0.75 | GABRA1 (0.39) | PDK2GABRA1GABRB2HTR7HTR2B | |
| SCHEMBL19690654 | 0.74 | PDK2 (0.41) | PDK2GABRA1GABRB2HTR7HTR2B | |
| SCHEMBL18663400 | 0.73 | PDK2 (0.40) | PDK2GABRA1GABRB2HTR7HTR2B | |
| SCHEMBL19690648 | 0.73 | PDK2 (0.40) | PDK2GABRA1GABRB2HTR7HTR2B | |
| SCHEMBL19690603 | 0.68 | KMT2A (0.34) | PDK2FFAR1 | |
| SCHEMBL18663335 | 0.61 | PDK2 (0.40) | PDK2PPARAGABRA1GABRB2HTR7 | |
| SCHEMBL27462033 | 0.59 | KDM4E (0.41) | BCHEACHEPTGS2 | |
| SCHEMBL18983054 | 0.57 | CLCN2 (0.56) | GABRA1GABRB2 | |
| SCHEMBL12283815 | 0.56 | ALDH1A1 (0.53) | PDK2GABRA1GABRB2 | |
| SCHEMBL9613867 | 0.56 | TP53 (0.55) | FFAR1GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190169328-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | RENQIU LIHE TECH LTD (CN) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169328-A1 | OLEFIN POLYMERIZATION CATALYST CARRIER, SOLID CATALYST COMPONENT AND USE THEREOF | COG2, GTF2I, POF1B | PDK2 3198/4885FFAR1 3146/4885PPARG 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.